Table 2.
Outcomes | 0VD (N = 988) |
DA (N = 302) |
1VD (N = 3295) |
2VD (N = 2114) |
3VD (N = 2190) |
---|---|---|---|---|---|
1-year | |||||
Death | 36 (3.6%) | 17 (5.6%) | 80 (2.4%) | 105 (5.0%) | 251 (11.5%) |
Recurrent MI | 35 (3.5%) | 19 (6.3%) | 273 (8.3%) | 285 (13.5%) | 369 (16.8%) |
Heart Failure | 101 (10.2%) | 40 (13.2%) | 263 (8.0%) | 249 (11.8%) | 433 (19.8%) |
Stroke | 17 (1.7%) | 4 (1.3%) | 42 (1.3%) | 37 (1.8%) | 69 (3.2%) |
5-years | |||||
Death | 120 (12.1%) | 55 (18.2%) | 327 (9.9%) | 315 (14.9%) | 609 (27.8%) |
Recurrent MI | 56 (5.7%) | 29 (9.6%) | 353 (10.7%) | 360 (17.0%) | 464 (21.2%) |
Heart Failure | 139 (14.1%) | 45 (14.9%) | 352 (10.7%) | 367 (17.4%) | 623 (28.4%) |
Stroke | 41 (4.1%) | 16 (5.3%) | 117 (3.6%) | 94 (4.4%) | 140 (6.4%) |
The results presented in numbers (percent)
Abbreviations: 0VD zero-vessel disease, DA diffuse atherosclerosis, 1VD one-vessel disease, 2VD two-vessel disease, 3VD three-vessel disease